Ad
related to: prostacyclin ip injection- Dosing & Titration
Information On Titration Scheduling
& Infusion Rate Calculation.
- Why Choose Pump Therapy?
Learn About The #1 Prescribed
Parenteral Therapy For PAH.
- Subcutaneous PAH Pump
Learn About This SC Pump That May
Fit Your Patients' Lives.
- Administration Options
Learn About SC & IV Administration
Options For Pump Treatment.
- Videos From Experts
See Videos From PAH Experts On
Dosing, Administration, & More.
- Adverse Reactions
Info To Prepare Your Patients On
Possible AEs They May Experience.
- Dosing & Titration
Search results
Results From The WOW.Com Content Network
The prostacyclin receptor, also termed the prostaglandin I 2 receptor or just IP, is a receptor belonging to the prostaglandin (PG) group of receptors. IP binds to and mediates the biological actions of prostacyclin (also termed prostaglandin I 2 , PGI 2 , or when used as a drug, epoprostenol).
Prostacyclin is produced in endothelial cells, which line the walls of arteries and veins, [14] from prostaglandin H 2 (PGH 2) by the action of the enzyme prostacyclin synthase. Although prostacyclin is considered an independent mediator, it is called PGI 2 (prostaglandin I 2 ) in eicosanoid nomenclature, and is a member of the prostanoids ...
Intraperitoneal injection or IP injection is the injection of a substance into the peritoneum (body cavity). It is more often applied to non-human animals than to humans. In general, it is preferred when large amounts of blood replacement fluids are needed or when low blood pressure or other problems prevent the use of a suitable blood vessel for intravenous injection.
Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). [3] [4] Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. [5]
They are named based on the prostanoid to which they preferentially bind and respond, e.g. the receptor responsive to PGI2 at lower concentrations than any other prostanoid is named the Prostacyclin receptor (IP). One exception to this rule is the receptor for thromboxane A2 (TP) which binds and responds to PGH2 and TXA2 equally well.
Iloprost is a synthetic analogue of prostacyclin PGI 2.Iloprost dilates systemic and pulmonary arterial vascular beds. It also affects platelet aggregation but the relevance of this effect to the treatment of pulmonary hypertension is unknown.
Chemical structure of prostaglandin E 1 (alprostadil) Chemical structure of prostaglandin I 2 (prostacyclin) Prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids [1] that have diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals.
Intraperitoneal injection (IP injection), the injection of a substance into the peritoneum; Prostacyclin receptor (symbol PTGIR, older synonym IP) Computing
Ad
related to: prostacyclin ip injection